 With markets in diabetes and wellness, Senseonics Eversense is an FDA-approved long-term implantable sensor that spells long-term growth for SENS stock. The post The Senseonics Price Will Start to Reflect the Key Advantage of Its Product appeared first on InvestorPlace. 